Here, we propose that miR-667-5p is involved in the DN process, and by targeting NLRC4, it inhibits NLRC4 inflammasome activation and inhibits the proliferation of renal tubular epithelial cells. This evidence concerns the gene NLRC4 and liver dysplastic nodule.